Regulatory compliance in medical device OEM contract manufacturing is not a separate function from manufacturing, it is woven into the manufacturing process itself. Every procedure in the quality management system reflects a regulatory requirement. Every record generated during production is a compliance artefact. Every audit of the manufacturing facility by the OEM’s quality team or by a regulatory authority is an assessment of whether the manufacturing operation is producing devices in the regulatory-compliant manner that the device’s approval and market registration requires.
For an OEM contract manufacturing relationship, this regulatory dimension defines the requirements that the contract manufacturing agreement must specify, the quality agreement must reinforce, and the manufacturing operation must consistently deliver. A contract manufacturer who treats regulatory compliance as a documentation exercise rather than an operational reality creates risks for the OEM that extend from product quality failures through to regulatory action against the OEM’s device registration.
AMT provides OEM contract manufacturing medical devices with regulatory compliance at the operational level, through a quality management system that is ISO 13485 certified and maintained in a state of genuine ongoing compliance rather than nominal compliance for audit purposes only.
The Regulatory Compliance Dimensions
Regulatory compliance in medical device contract manufacturing has several dimensions. The quality management system compliance dimension is whether the QMS documentation meets the applicable standard and whether the QMS is actually implemented as documented. The production compliance dimension is whether manufacturing produces devices that consistently meet their specification. The documentation compliance dimension is whether the records accurately reflect the production activities and outcomes.
OEM contract manufacturing medical devices at AMT addresses all three dimensions. The QMS is ISO 13485 certified, with third-party surveillance audits confirming ongoing compliance. Production quality is monitored through process performance metrics. Documentation accuracy is verified through batch record review at each lot close.
Regulatory Intelligence for Contract Manufacturers
Medical device regulations are not static. The EU MDR replaced the previous MDD and AIMDD with significantly enhanced requirements for technical documentation, clinical evidence, and post-market surveillance. The FDA continues to issue guidance documents and update its regulatory expectations for specific device categories. Health Sciences Authority in Singapore periodically updates its requirements for locally registered devices.
A contract manufacturer whose regulatory knowledge is frozen at the point of their last certification audit may be producing to requirements that have been superseded. AMT maintains regulatory intelligence through industry participation and active monitoring of regulatory developments in the key markets served by its OEM customers.
Audit Support for OEM Customers
The OEM’s quality assurance obligation extends to auditing its critical suppliers, including its contract manufacturers. A well-prepared contract manufacturer who responds to audit requests efficiently, provides complete and accurate documentation, and can explain the quality management system’s operation clearly reduces the OEM’s audit burden and produces better audit outcomes.
AMT’s quality team prepares for OEM supplier audits as a standard part of its customer relationship management, with all required documentation accessible and the relevant personnel available to support the audit activities.
Post-Market Surveillance Support
After devices are distributed, post-market surveillance activities monitor device performance in the field and feed safety and performance data back into the risk management and design control processes. When a field issue is identified that may have a manufacturing cause, the contract manufacturer’s production records and quality data are the primary source of investigation evidence.
AMT maintains production records for the regulatory minimum retention period, with the records organised to support efficient retrieval for post-market investigation purposes. Nonconformance and CAPA records are similarly maintained and accessible.
For medical device OEM companies who need OEM contract manufacturing medical devices with genuine regulatory compliance at the operational level, not just the certification level, AMT’s regulated contract manufacturing service provides the quality management infrastructure and compliance discipline that OEM medical device production in Singapore demands.